THERMO FISHER SCIENTIFIC INC.
SEC EDGAR quarterly and annual company filings
Past bets that played out
These are the clearest thesis calls with observable outcomes, linked back to the original videos.
Excerpt is the header of Thermo Fisher Scientific Inc. (TMO) Form 10‑Q for quarter ended 2026‑03‑28 plus a list of NYSE-listed securities (common stock and multiple note issues). No operating results, guidance, segment trends, or risk updates are included in the provided text, so there is little directly tradable incremental information.
Extracted only the cover-page/security-registration portion of Thermo Fisher Scientific’s FY2025 Form 10-K. No financial results, guidance, risk updates, or segment commentary were provided in the snippet, so investable conclusions are limited. The text does confirm TMO common stock and multiple NYSE-listed note issues outstanding and that TMO is a well-known seasoned issuer (WKSI).
The provided excerpt is only the cover page/header of Thermo Fisher Scientific’s Form 10‑Q for the quarter ended Sep 27, 2025, plus a list of listed securities (common stock and multiple exchange-listed note tickers). It contains no financial statements, segment results, guidance updates, risk-factor changes, or management commentary—so it is not actionable for fundamental signal extraction.
What this channel is watching now
Recent mentions show where this author is concentrating attention right now.
Latest videos and market context
Recent source posts from this author. Create an account to inspect the complete persisted research trail.
GEV 10-Q report for 2026-06-30
The provided excerpt is only the Form 10‑Q cover page for GE Vernova Inc. (GEV) for quarter ended 2026‑06‑30, with no financial statements, MD&A, segment results, guidance, backlog, risks, or other performance details included. As-is, it contains almost no trade-relevant incremental information beyond confirming the filing/period and listing details.
SNBR 10-Q report for 2026-04-04
This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.
SOUN 10-Q report for 2026-03-31
The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.
WEAT 10-Q report for 2026-03-31
The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).
Proof-backed call history
These are recent thesis calls tied to original source content where available.
Excerpt is the header of Thermo Fisher Scientific Inc. (TMO) Form 10‑Q for quarter ended 2026‑03‑28 plus a list of NYSE-listed securities (common stock and multiple note issues). No operating results, guidance, segment trends, or risk updates are included in the provided text, so there is little directly tradable incremental information.
Extracted only the cover-page/security-registration portion of Thermo Fisher Scientific’s FY2025 Form 10-K. No financial results, guidance, risk updates, or segment commentary were provided in the snippet, so investable conclusions are limited. The text does confirm TMO common stock and multiple NYSE-listed note issues outstanding and that TMO is a well-known seasoned issuer (WKSI).
The provided excerpt is only the cover page/header of Thermo Fisher Scientific’s Form 10‑Q for the quarter ended Sep 27, 2025, plus a list of listed securities (common stock and multiple exchange-listed note tickers). It contains no financial statements, segment results, guidance updates, risk-factor changes, or management commentary—so it is not actionable for fundamental signal extraction.
Excerpt shows only the header/cover page of Thermo Fisher Scientific Inc. Form 10-Q for quarter ended June 28, 2025, including listing of registered securities (TMO common stock and multiple NYSE-listed note issues). No financial statements, MD&A, guidance, risk updates, segment performance, or material events are included in the provided text, so no fundamental catalysts can be assessed from this excerpt alone.
About this channel
Channel bio, source link, and public-market context from YouTube.
SEC EDGAR quarterly and annual company filings
Most recognized assets
Unlock the full track record
Create an account to inspect the complete author history, trust-weighted rankings, and persisted research across authors, theses, and assets.